GlassScriptPhysician profile
Bindu M Kamal
NPI 1184718215
$2,291.73
in general payments reported to CMS, 2019-2025
15 companies · $628 in 2025
The $628 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $83.32 · 2021: $219 · 2022: $249 · 2023: $560 · 2024: $259 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,434 · Education: $13.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,433.51 |
| Education | $13.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $795.95 | 2019-2025 | Farxiga, Lokelma |
| Calliditas Therapeutics US INC. | $328.80 | 2023-2025 | Tarpeyo |
| Bayer Healthcare Pharmaceuticals INC. | $230.99 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.14 | 2024-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $165.30 | 2019-2020 | |
| Vifor Pharma, INC. | $160.10 | 2019-2022 | |
| Amgen INC. | $60.20 | 2019-2024 | Aranesp, Parsabiv, Tavneos |
| Nxstage Medical, INC. | $58.48 | 2022-2023 | Liberty Select Cycler |
| Horizon Therapeutics Plc | $56.72 | 2019-2021 | |
| Akebia Therapeutics INC | $50.86 | 2025 | Vafseo |
| Glaxosmithkline, LLC. | $41.68 | 2021-2023 | Benlysta |
| Fresenius USA Marketing, INC. | $40.97 | 2020 | |
| Lemaitre Vascular, INC. | $40.22 | 2025 | Artegraft Vascular Graft |
| Travere Therapeutics, INC. | $24.10 | 2025 | |
| Ardelyx, INC. | $22.22 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindu Kamal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.